Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial (vol 22, pg 209, 2023)

被引：0
|
作者：
Lipton, R. B.
Croop, R.
Stock, D. A.
机构：
来源：
LANCET NEUROLOGY | 2023年 / 22卷 / 05期
关键词：
D O I：
10.1016/S1474-4422(23)00107-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：e7 / e7
页数：1
相关论文
共 50 条
  • [1] Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA : a phase 3, double-blind, randomised, placebo-controlled multicentre trial
    Lipton, Richard B.
    Croop, Robert
    Stock, David A.
    Madonia, Jennifer
    Forshaw, Micaela
    Lovegren, Meghan
    Mosher, Linda
    Coric, Vladimir
    Goadsby, Peter J.
    [J]. LANCET NEUROLOGY, 2023, 22 (03):
  • [2] Efficacy and Safety of Zavegepant Nasal Spray for the Acute Treatment of Migraine: Results of a Phase 3 Double-Blind, Randomized, Placebo Controlled Trial
    Mullin, K.
    Croop, R.
    Pavlovic, J.
    Mosher, L.
    Smith, T.
    Madonia, J.
    Lovegren, M.
    Coric, V.
    Lipton, R.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [3] Efficacy and Safety of Zavegepant Nasal Spray for the Acute Treatment of Migraine: Results of a Phase 3 Double-Blind, Randomized, Placebo Controlled Trial
    Mullin, Kathleen
    Croop, Robert
    Pavlovic, Jelena
    Mosher, Linda
    Smith, Timothy
    Madonia, Jennifer
    Lovegren, Meghan
    Lipton, Richard
    [J]. NEUROLOGY, 2023, 100 (17)
  • [4] Efficacy and safety of zavegepant nasal spray for the acute treatment of migraine: Results of a phase 3 double-blind, randomized, placebo controlled trial
    Mullin, K.
    Croop, R.
    Pavlovic, J. M.
    Mosher, L.
    Smith, T. R.
    Madonia, J.
    Lovegren, M.
    Coric, V
    Lipton, R. B.
    [J]. HEADACHE, 2022, 62 : 128 - 129
  • [5] Efficacy and Safety of Zavegepant Nasal Spray for the Acute Treatment of Migraine: Results of a Phase 3 Double-Blind, Randomized, Placebo Controlled Trial
    Mullin, Kathleen
    Croop, Robert
    Pavlovic, Jelena M.
    Mosher, Linda
    Smith, Timothy R.
    Madonia, Jennifer
    Lovegren, Meghan
    Coric, Vladimir
    Lipton, Richard B.
    [J]. CEPHALALGIA, 2022, 42 (1_SUPPL) : 126 - 127
  • [6] Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double-blind, randomized, placebo-controlled, dose-ranging trial
    Croop, Robert
    Madonia, Jennifer
    Stock, David A.
    Thiry, Alexandra
    Forshaw, Micaela
    Murphy, Abigail
    Coric, Vladimir
    Lipton, Richard B.
    [J]. HEADACHE, 2022, 62 (09): : 1153 - 1163
  • [7] Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine - A randomised, double-blind, placebo-controlled study
    Dodick, D
    Brandes, J
    Elkind, A
    Mathew, N
    Rodichok, L
    [J]. CNS DRUGS, 2005, 19 (02) : 125 - 136
  • [8] Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial
    Croop, Robert
    Goadsby, Peter J.
    Stock, David A.
    Conway, Charles M.
    Forshaw, Micaela
    Stock, Elyse G.
    Coric, Vladimir
    Lipton, Richard B.
    [J]. LANCET, 2019, 394 (10200): : 737 - 745
  • [9] Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA
    Dodick, David W.
    Goadsby, Peter J.
    Schwedt, Todd J.
    Lipton, Richard B.
    Liu, Chengcheng
    Lu, Kaifeng
    Yu, Sung Yun
    Severt, Lawrence
    Finnegan, Michelle
    Trugman, Joel M.
    [J]. LANCET, 2023, 402 (10419): : 2307 - 2316
  • [10] Speed of Onset, Efficacy and Tolerability of Zolmitriptan Nasal Spray in the Acute Treatment of MigraineA Randomised, Double-Blind, Placebo-Controlled Study
    David Dodick
    Jan Brandes
    Arthur Elkind
    Ninan Mathew
    Lawrence Rodichok
    [J]. CNS Drugs, 2005, 19 : 125 - 136
12345